Universität zu Köln

Paffenholz, Pia, Seidel, Christoph, Nestler, Tim, Pfister, David and Heidenreich, Axel . Thromboembolic complications and prophylactic anticoagulation in advanced testicular germ cell tumours. Onkologe. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Full text not available from this repository.

Abstract

Background Testicular germ cell tumours (TGCT) represent the most common solid neoplasms in young men. Due to the high chemosensitivity, excellent cure rates can be achieved even in metastatic stages. However, thromboembolic complications represent a common event which can impair excellent cure rates in this group of patients. Objectives This article provides a literature review on incidence, location, implications as well as risk factors for the development of venous thromboembolic complications in TCGT patients receiving cisplatin-based chemotherapy and gives an overview on prophylactic anticoagulation. Materials and methods A literature search in PubMed was performed. Results Treatment-associated venous thromboembolic complications occur in up to 19% of all TGCT patients receiving cisplatin-based chemotherapy, most commonly as a pulmonary embolism or deep venous thrombosis. As a result, thromboembolic complications can lead to a reduced overall survival in these patients. Large tumor masses, elevated LDH, endothelial dysfunction and a central venous access were identified as risk factors for the development of venous thromboembolic complications. Current international guidelines remain vague and recommend the use of thromboprophylaxis in high-risk patients. Conclusions TGCT patients undergoing cisplatin-based chemotherapy are at high risk for the development of venous thromboembolic complications, potentially leading to a higher treatment morbidity. Further studies are needed to determine appropriate risk stratification for these patients.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Paffenholz, Pia UNSPECIFIED UNSPECIFIED UNSPECIFIED Seidel, Christoph UNSPECIFIED UNSPECIFIED UNSPECIFIED Nestler, Tim UNSPECIFIED UNSPECIFIED UNSPECIFIED Pfister, David UNSPECIFIED UNSPECIFIED UNSPECIFIED Heidenreich, Axel UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-307938
DOI:	10.1007/s00761-020-00879-3
Journal or Publication Title:	Onkologe
Publisher:	SPRINGER HEIDELBERG
Place of Publication:	HEIDELBERG
ISSN:	1433-0415
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language CISPLATIN-BASED CHEMOTHERAPY; VENOUS THROMBOEMBOLISM; CANCER-PATIENTS; EVENTS; RISK; PLATINUM; THROMBOPROPHYLAXIS; THROMBOSIS; DISEASE Multiple languages Oncology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/30793